These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 18711292

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
    Nikzamir A, Nakhjavani M, Esteghamati A, Rashidi A.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1274-7. PubMed ID: 17986476
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Sequence variation in the human angiotensin converting enzyme.
    Rieder MJ, Taylor SL, Clark AG, Nickerson DA.
    Nat Genet; 1999 May; 22(1):59-62. PubMed ID: 10319862
    [Abstract] [Full Text] [Related]

  • 49. Prevalence of the angiotensin I converting enzyme gene insertion/deletion polymorphism in a healthy Turkish population.
    Berdeli A, Cam FS.
    Biochem Genet; 2009 Jun; 47(5-6):412-20. PubMed ID: 19390959
    [Abstract] [Full Text] [Related]

  • 50. The IkappaBL gene polymorphism influences risk of acquiring systemic lupus erythematosus and Sjögren's syndrome.
    Castiblanco J, Anaya JM.
    Hum Immunol; 2008 Jan; 69(1):45-51. PubMed ID: 18295675
    [Abstract] [Full Text] [Related]

  • 51. The IL-16 gene polymorphisms and the risk of the systemic lupus erythematosus.
    Xue H, Gao L, Wu Y, Fang W, Wang L, Li C, Li Y, Liang W, Zhang L.
    Clin Chim Acta; 2009 May; 403(1-2):223-5. PubMed ID: 19298795
    [Abstract] [Full Text] [Related]

  • 52. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.
    Kümpers P, David S, Haubitz M, Hellpap J, Horn R, Bröcker V, Schiffer M, Haller H, Witte T.
    Ann Rheum Dis; 2009 Oct; 68(10):1638-43. PubMed ID: 18930996
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Association study of ACE polymorphisms and systemic lupus erythematosus in Northern Chinese Han population.
    Gong AM, Li XY, Wang YQ, Yan HX, Xu ZX, Feng Z, Xie YQ, Yin DH, Yang SZ.
    Mol Biol Rep; 2012 Oct; 39(10):9485-91. PubMed ID: 22729880
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Fcgamma receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.
    Lee YH, Ji JD, Song GG.
    Lupus; 2009 Jul; 18(8):727-34. PubMed ID: 19502269
    [Abstract] [Full Text] [Related]

  • 58. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A, da Silva LM, Oliveira FR, Roselino AM, Louzada-Junior P.
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.